Abstract
Celiac disease (CD) is an immune-mediated inflammatory enteropathy triggered by gluten exposure in genetically susceptible individuals. It has a high prevalence approaching 1% of the US population. A high index of suspicion is warranted to diagnose CD as frequently patients present with extraintestinal or atypical manifestations. CD is diagnosed by a combination of serum serologies and duodenal biopsies. The majority of patients will respond to a lifelong gluten-free diet which is the cornerstone of therapy. Complications such as refractory CD, ulcerative jejunoileitis, enteropathy associated T-cell lymphoma and small bowel adenocarcinoma occur in a minority of patients.
Similar content being viewed by others
Abbreviations
- CD:
-
Celiac disease
- GFD:
-
Gluten-free diet
- EATL:
-
Enteropathy-associated T-cell lymphoma
References
Fasano A, Berti I, Gerarduzzi T, et al. (2003) Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 163(3):286–292
Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE (2012) The prevalence of celiac disease in the United States. Am J Gastroenterol 107(10):1538–1544 (quiz 1537). doi:10.1038/ajg.2012.219
Kim HS, Patel KG, Orosz E, et al. (2016) Time trends in the prevalence of celiac disease and gluten-free diet in the US population: results from the National Health and Nutrition Examination surveys 2009–2014. JAMA Intern Med 176(111):1716–1717
Choung RS, Ditah IC, Nadeau AM, et al. (2015) Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: findings from the National Health and Nutrition Examination Surveys from 1988 to 2012. Am J Gastroenterol 110(3):455–461. doi:10.1038/ajg.2015.8
Tommasini A, Not T, Kiren V, et al. (2004) Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch Dis Child 89(6):512–515
Catassi C, Fanciulli G, D’Appello AR, et al. (2000) Antiendomysium versus antigliadin antibodies in screening the general population for coeliac disease. Scand J Gastroenterol 35(7):732–736
Trevisiol C, Not T, Berti I, et al. (1999) Screening for coeliac disease in healthy blood donors at two immuno-transfusion centres in north-east Italy. Ital J Gastroenterol Hepatol 31(7):584–586
Volta U, Bellentani S, Bianchi FB, et al. (2001) High prevalence of celiac disease in Italian general population. Dig Dis Sci 46(7):1500–1505
West J, Logan RF, Hill PG, et al. (2003) Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 52(7):960–965
Carlsson AK, Axelsson IE, Borulf SK, Bredberg AC, Ivarsson SA (2001) Serological screening for celiac disease in healthy 2.5-year-old children in Sweden. Pediatrics 107(1):42–45
Walker MM, Murray JA, Ronkainen J, et al. (2010) Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology 139(1):112–119. doi:10.1053/j.gastro.2010.04.007
Kolho KL, Farkkila MA, Savilahti E (1998) Undiagnosed coeliac disease is common in Finnish adults. Scand J Gastroenterol 33(12):1280–1283
Mäki M, Mustalahti K, Kokkonen J, et al. (2003) Prevalence of celiac disease among children in Finland. N Engl J Med 348(25):2517–2524. doi:10.1056/NEJMoa021687
Csizmadia CGDS, Mearin ML, von Blomberg BME, Brand R, Verloove-Vanhorick SP (1999) An iceberg of childhood coeliac disease in the Netherlands. Lancet 353(9155):813–814. doi:10.1016/S0140-6736(99)00243-3
Catassi C, Ratsch IM, Gandolfi L, et al. (1999) Why is coeliac disease endemic in the people of the Sahara? Lancet (London, England) 354(9179):647–648
Barada K, Bitar A, Mokadem MA, Hashash JG, Green P (2010) Celiac disease in Middle Eastern and North African countries: a new burden? World J Gastroenterol 16(12):1449–1457
Rewers M (2005) Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology 128(4 Suppl 1):S47–S51
Cummins AG, Roberts-Thomson IC (2009) Prevalence of celiac disease in the Asia-Pacific region. J Gastroenterol Hepatol 24(8):1347–1351. doi:10.1111/j.1440-1746.2009.05932.x
Abadie V, Sollid LM, Barreiro LB, Jabri B (2011) Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol 29:493–525
Tack GJ, Verbeek WH, Schreurs MW, Mulder CJ (2010) The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol 7(4):204–213. doi:10.1038/nrgastro.2010.23
Murray JA, Van Dyke C, Plevak MF, et al. (2003) Trends in the identification and clinical features of celiac disease in a North American community, 1950–2001. Clin Gastroenterol Hepatol 1(1):19–27. doi:10.1053/jcgh.2003.50004
Ludvigsson JF, Rubio-Tapia A, van Dyke CT, et al. (2013) Increasing incidence of celiac disease in a North American population. Am J Gastroenterol 108(5):818–824. doi:10.1038/ajg.2013.60
Riddle MS, Murray JA, Porter CK (2012) The incidence and risk of celiac disease in a healthy US adult population. Am J Gastroenterol 107(8):1248–1255. doi:10.1038/ajg.2012.130
Dixit R, Lebwohl B, Ludvigsson JF, et al. (2014) Celiac disease is diagnosed less frequently in young adult males. Dig Dis Sci 59(7):1509–1512. doi:10.1007/s10620-014-3025-6
Green PHR, Stavropoulos SN, Panagi SG, et al. (2001) Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 96(1):126–131. doi:10.1111/j.1572-0241.2001.03462.x
Dogan Y, Yildirmaz S, Ozercan IH (2012) Prevalence of celiac disease among first-degree relatives of patients with celiac disease. J Pediatr Gastroenterol Nutr 55(2):205–208. doi:10.1097/MPG.0b013e318249378c
Ploski R, Ek J, Thorsby E, Sollid LM (1993) On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 41(4):173–177
Rubio-Tapia A, Van Dyke CT, Lahr BD, et al. (2008) Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol 6(9):983–987. doi:10.1016/j.cgh.2008.04.008
Greco L, Romino R, Coto I, et al. (2002) The first large population based twin study of coeliac disease. Gut 50(5):624–628
Karell K, Louka AS, Moodie SJ, et al. (2003) HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 64(4):469–477
Hadithi M, von Blomberg BM, Crusius JB, et al. (2007) Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med 147(5):294–302
Lebwohl B, Rubio-Tapia A, Assiri A, Newland C, Guandalini S (2012) Diagnosis of celiac disease. Gastrointest Endosc Clin N Am 22(4):661–677. doi:10.1016/j.giec.2012.07.004
Sollid LM, Thorsby E (1990) The primary association of celiac disease to a given HLA-DQ alpha/beta heterodimer explains the divergent HLA-DR associations observed in various Caucasian populations. Tissue Antigens 36(3):136–137
Trynka G, Zhernakova A, Romanos J, et al. (2009) Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. Gut 58(8):1078–1083. doi:10.1136/gut.2008.169052
Garner CP, Murray JA, Ding YC, et al. (2009) Replication of celiac disease UK genome-wide association study results in a US population. Hum Mol Genet 18(21):4219–4225. doi:10.1093/hmg/ddp364
Vriezinga SL, Auricchio R, Bravi E, et al. (2014) Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med 371(14):1304–1315
Lionetti E, Castellaneta S, Francavilla R, et al. (2014) Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med 371(14):1295–1303
Andren Aronsson C, Lee HS, Koletzko S, et al. (2016) Effects of gluten intake on risk of celiac disease: a case–control study on a Swedish Birth cohort. Clin Gastroenterol Hepatol 14(3):403–409
Marild K, Stephansson O, Montgomery S, Murray JA, Ludvigsson JF (2012) Pregnancy outcome and risk of celiac disease in offspring: a nationwide case–control study. Gastroenterology 142(1):39–45
Marild K, Ye W, Lebwohl B, et al. (2013) Antibiotic exposure and the development of coeliac disease: a nationwide case–control study. BMC Gastroenterol 13(109):13–109
Ludvigsson JF, Nordenvall C, Jarvholm B (2014) Smoking, use of moist snuff and risk of celiac disease: a prospective study. BMC Gastroenterol 14(120):14–120
Patel AH, Loftus EV, Murray JA, et al. (2001) Cigarette smoking and celiac sprue: a case–control study. Am J Gastroenterol 96(8):2388–2391
Binder HJ (2015) Disorders of absorption. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson JL, Loscalzo J (eds) Harrison’s principles of internal medicine, 19th edn. New York: McGraw-Hill Education
S G (1890) On the coeliac affection. St Bart Hosp Rep: 2417–2420
Rashid M, Cranney A, Zarkadas M, et al. (2005) Celiac disease: evaluation of the diagnosis and dietary compliance in Canadian children. Pediatrics 116(6):e754–e759. doi:10.1542/peds.2005-0904
Telega G, Bennet TR, Werlin S (2008) Emerging new clinical patterns in the presentation of celiac disease. Arch Pediatr Adolesc Med 162(2):164–168. doi:10.1001/archpediatrics.2007.38
Guandalini S, Assiri A (2014) Celiac disease: a review. JAMA Pediatr 168(3):272–278. doi:10.1001/jamapediatrics.2013.3858
Skowera A, Peakman M, Cleare A, et al. (2001) High prevalence of serum markers of coeliac disease in patients with chronic fatigue syndrome. J Clin Pathol 54(4):335–336
Sanders DS, Patel D, Stephenson TJ, et al. (2003) A primary care cross-sectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol 15(4):407–413
Halfdanarson TR, Litzow MR, Murray JA (2007) Hematologic manifestations of celiac disease. Blood 109(2):412–421. doi:10.1182/blood-2006-07-031104
Hanif FM, Luck NH, Abbas Z, et al. (2015) Early, non-refractory celiac disease associated with microscopic colitis and splenomegaly. J Coll Phys Surg-Pakistan 25(Suppl 1):S14–S16
Sadr-Azodi O, Sanders DS, Murray JA, Ludvigsson JF (2012) Patients with celiac disease have an increased risk for pancreatitis. Clin Gastroenterol Hepatol 10(10):1136–1142
Briggs JH, McKean D, Palmer JS, Bungay H (2014) Transient small bowel intussusception in adults: an overlooked feature of coeliac disease. BMJ Case Rep 20(10):2013–203156
Jakes AD, Bradley S, Donlevy L (2014) Dermatitis herpetiformis. BMJ 348:g2557. doi:10.1136/bmj.g2557
Collin P, Reunala T, Rasmussen M, et al. (1997) High incidence and prevalence of adult coeliac disease. Augmented diagnostic approach. Scand J Gastroenterol 32(11):1129–1133
Caproni M, Bonciolini V, D’Errico A, Antiga E, Fabbri P (2012) Celiac disease and dermatologic manifestations: many skin clue to unfold gluten-sensitive enteropathy. Gastroenterol Res Pract 2012:952753. doi:10.1155/2012/952753
Freeman HJ (2008) Neurological disorders in adult celiac disease. Can J Gastroenterol 22(11):909–911
Fisher AH, Lomasky SJ, Fisher MJ, Oppenheim YL (2008) Celiac disease and the endocrinologist: a diagnostic opportunity. Endocr Pract 14(3):381–388. doi:10.4158/ep.14.3.381
Ludvigsson JF, Sellgren C, Runeson B, Langstrom N, Lichtenstein P (2011) Increased suicide risk in coeliac disease—a Swedish nationwide cohort study. Dig Liver Dis 43(8):616–622. doi:10.1016/j.dld.2011.02.009
Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA (2013) ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 108(5):656–676 (quiz 677). doi:10.1038/ajg.2013.79
Lewis NR, Scott BB (2010) Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 31(1):73–81. doi:10.1111/j.1365-2036.2009.04110.x
Giersiepen K, Lelgemann M, Stuhldreher N, et al. (2012) Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report. J Pediatr Gastroenterol Nutr 54(2):229–241. doi:10.1097/MPG.0b013e318216f2e5
Amarri S, Alvisi P, De Giorgio R, et al. (2013) Antibodies to deamidated gliadin peptides: an accurate predictor of coeliac disease in infancy. J Clin Immunol 33(5):1027–1030. doi:10.1007/s10875-013-9888-z
McGowan KE, Lyon ME, Butzner JD (2008) Celiac disease and IgA deficiency: complications of serological testing approaches encountered in the clinic. Clin Chem 54(7):1203–1209. doi:10.1373/clinchem.2008.103606
Lee SK, Green PH (2005) Endoscopy in celiac disease. Curr Opin Gastroenterol 21(5):589–594
Dickson BC, Streutker CJ, Chetty R (2006) Coeliac disease: an update for pathologists. J Clin Pathol 59(10):1008–1016. doi:10.1136/jcp.2005.035345
Oberhuber G (2000) Histopathology of celiac disease. Biomed Pharmacother 54(7):368–372. doi:10.1016/s0753-3322(01)80003-2
Corazza GR, Villanacci V, Zambelli C, et al. (2007) Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease. Clin Gastroenterol Hepatol 5(7):838–843. doi:10.1016/j.cgh.2007.03.019
Husby S, Koletzko S, Korponay-Szabo IR, et al. (2012) European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 54(1):136–160. doi:10.1097/MPG.0b013e31821a23d0
Kurppa K, Salminiemi J, Ukkola A, et al. (2012) Utility of the new ESPGHAN criteria for the diagnosis of celiac disease in at-risk groups. J Pediatr Gastroenterol Nutr 54(3):387–391. doi:10.1097/MPG.0b013e3182407c6b
Klapp G, Masip E, Bolonio M, et al. (2013) Celiac disease: the new proposed ESPGHAN diagnostic criteria do work well in a selected population. J Pediatr Gastroenterol Nutr 56(3):251–256. doi:10.1097/MPG.0b013e318279887b
Mubarak A, Wolters VM, Gerritsen SA, et al. (2011) A biopsy is not always necessary to diagnose celiac disease. J Pediatr Gastroenterol Nutr 52(5):554–557. doi:10.1097/MPG.0b013e3181ef8e50
Barker CC, Mitton C, Jevon G, Mock T (2005) Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations? Pediatrics 115(5):1341–1346. doi:10.1542/peds.2004-1392
Alessio MG, Tonutti E, Brusca I, et al. (2012) Correlation between IgA tissue transglutaminase antibody ratio and histological finding in celiac disease. J Pediatr Gastroenterol Nutr 55(1):44–49. doi:10.1097/MPG.0b013e3182470249
Donaldson MR, Book LS, Leiferman KM, Zone JJ, Neuhausen SL (2008) Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease. J Clin Gastroenterol 42(3):256–260. doi:10.1097/MCG.0b013e31802e70b1
Trovato CM, Montuori M, Anania C, et al. (2015) Are ESPGHAN “biopsy-sparing” guidelines for celiac disease also suitable for asymptomatic patients? Am J Gastroenterol 110(10):1485–1489. doi:10.1038/ajg.2015.285
Saginur M, AlRefaee FAM, Spady DW, et al. (2013) Antitissue transglutaminase antibody determination versus upper endoscopic biopsy diagnosis of paediatric celiac disease. Paediatr Child Health 18(5):246–250
Wakim-Fleming J, Pagadala MR, Lemyre MS, et al. (2013) Diagnosis of celiac disease in adults based on serology test results, without small-bowel biopsy. Clin Gastroenterol Hepatol 11(5):511–516. doi:10.1016/j.cgh.2012.12.015
Salmi TT, Collin P, Reunala T, Maki M, Kaukinen K (2010) Diagnostic methods beyond conventional histology in coeliac disease diagnosis. Dig Liver Dis 42(1):28–32. doi:10.1016/j.dld.2009.04.004
Catassi C, Fasano A (2010) Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med 123(8):691–693. doi:10.1016/j.amjmed.2010.02.019
Rubio-Tapia A, Rahim MW, See JA, et al. (2010) Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol 105(6):1412–1420. doi:10.1038/ajg.2010.10
Megiorni F, Pizzuti A (2012) HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing. J Biomed Sci 19:88. doi:10.1186/1423-0127-19-88
Kaukinen K, Partanen J, Mäki M, Collin P (2002) HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol 97(3):695–699. doi:10.1016/S0002-9270(01)04033-3
Lauret E, Rodrigo L (2013) Celiac disease and autoimmune-associated conditions. BioMed Res Int 2013:127589. doi:10.1155/2013/127589
Poulain C, Johanet C, Delcroix C, Levy-Marchal C, Tubiana-Rufi N (2007) Prevalence and clinical features of celiac disease in 950 children with type 1 diabetes in France. Diabetes Metab 33(6):453–458. doi:10.1016/j.diabet.2007.06.004
Pham-Short A, Donaghue KC, Ambler G, et al. (2015) Screening for celiac disease in type 1 diabetes: a systematic review. Pediatrics 136(1):e170–e176
Hadithi M, de Boer H, Meijer JW, et al. (2007) Coeliac disease in Dutch patients with Hashimoto’s thyroiditis and vice versa. World J Gastroenterol 13(11):1715–1722
Sategna-Guidetti C, Volta U, Ciacci C, et al. (2001) Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal: an Italian multicenter study. Am J Gastroenterol 96(3):751–757. doi:10.1111/j.1572-0241.2001.03617.x
Ansaldi N, Palmas T, Corrias A, et al. (2003) Autoimmune thyroid disease and celiac disease in children. J Pediatr Gastroenterol Nutr 37(1):63–66
Elfstrom P, Montgomery SM, Kampe O, Ekbom A, Ludvigsson JF (2008) Risk of thyroid disease in individuals with celiac disease. J Clin Endocrinol Metab 93(10):3915–3921. doi:10.1210/jc.2008-0798
Meloni A, Mandas C, Jores RD, Congia M (2009) Prevalence of autoimmune thyroiditis in children with celiac disease and effect of gluten withdrawal. J Pediatr 155(1):51–55, 55.e51. doi:10.1016/j.jpeds.2009.01.013
Kingham JG, Parker DR (1998) The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 42(1):120–122
Floreani A, Betterle C, Baragiotta A, et al. (2002) Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy. Dig Liver Dis 34(4):258–261
Ludvigsson JF, Elfstrom P, Broome U, Ekbom A, Montgomery SM (2007) Celiac disease and risk of liver disease: a general population-based study. Clin Gastroenterol Hepatol 5(1):63–69.e61. doi:10.1016/j.cgh.2006.09.034
Rubio-Tapia A, Herman ML, Ludvigsson JF, et al. (2012) Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc 87(8):732–738. doi:10.1016/j.mayocp.2012.06.003
DeGaetani M, Tennyson CA, Lebwohl B, et al. (2013) Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma. Am J Gastroenterol 108(5):647–653. doi:10.1038/ajg.2013.45
Akobeng AK, Thomas AG (2008) Systematic review: tolerable amount of gluten for people with coeliac disease. Aliment Pharmacol Ther 27(11):1044–1052. doi:10.1111/j.1365-2036.2008.03669.x
Catassi C, Rossini M, Rätsch IM, et al. (1993) Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study. Gut 34(11):1515–1519
Catassi C, Fabiani E, Iacono G, et al. (2007) A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr 85(1):160–166
Standard for Foods for Special Dietary Use for Persons Intolerant to Gluten. Codex Committee on Nutrition and Foods for Special Dietary Uses, vol Adopted in 1979. Amendment: 1983 and 2015. Revision: 2008.
Janatuinen EK, Kemppainen TA, Julkunen RJ, et al. (2002) No harm from five year ingestion of oats in coeliac disease. Gut 50(3):332–335
Sey MS, Parfitt J, Gregor J (2011) Prospective study of clinical and histological safety of pure and uncontaminated Canadian oats in the management of celiac disease. JPEN J Parenter Enteral Nutr 35(4):459–464. doi:10.1177/0148607110387800
Kemppainen TA, Heikkinen MT, Ristikankare MK, Kosma VM, Julkunen RJ (2010) Nutrient intakes during diets including unkilned and large amounts of oats in celiac disease. Eur J Clin Nutr 64(1):62–67. doi:10.1038/ejcn.2009.113
Thompson T, Dennis M, Higgins LA, Lee AR, Sharrett MK (2005) Gluten-free diet survey: are Americans with coeliac disease consuming recommended amounts of fibre, iron, calcium and grain foods? J Hum Nutr Diet 18(3):163–169. doi:10.1111/j.1365-277X.2005.00607.x
Pink IJ, Creamer B (1967) Response to a gluten-free diet of patients with the coeliac syndrome. Lancet 1(7485):300–304
Rashtak S, Murray JA (2012) Review article: celiac disease, new approaches to therapy. Aliment Pharmacol Ther 35(7):768–781. doi:10.1111/j.1365-2036.2012.05013.x
Leffler DA, Dennis M, Hyett B, et al. (2007) Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol 5(4):445–450
O’Mahony S, Howdle PD, Losowsky MS (1996) Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther 10(5):671–680
Abdulkarim AS, Burgart LJ, See J, Murray JA (2002) Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol 97(8):2016–2021
van Gils T, Nijeboer P, van Wanrooij RL, Bouma G, Mulder CJ (2015) Mechanisms and management of refractory coeliac disease. Nat Rev Gastroenterol Hepatol 12(10):572–579
Roshan B, Leffler DA, Jamma S, et al. (2011) The incidence and clinical spectrum of refractory celiac disease in a north american referral center. Am J Gastroenterol 106(5):923–928
Rubio-Tapia A, Murray JA (2010) Classification and management of refractory coeliac disease. Gut 59(4):547–557
Malamut G, Afchain P, Verkarre V, et al. (2009) Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 136(1):81–90
Rubio-Tapia A, Kelly DG, Lahr BD, et al. (2009) Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology 136(1):99–107
Al-Toma A, Verbeek WH, Hadithi M, von Blomberg BM, Mulder CJ (2007) Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 56(10):1373–1378
Delabie J, Holte H, Vose JM, et al. (2011) Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood 118(1):148–155
Sieniawski M, Angamuthu N, Boyd K, et al. (2010) Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. Blood 115(18):3664–3670
Siegel RL, Miller KD, Jemal A (2016) Cancer statistics. CA Cancer J Clin 66(1):7–30
Askling J, Linet M, Gridley G, et al. (2002) Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 123(5):1428–1435
Brousse N, Meijer JW (2005) Malignant complications of coeliac disease. Best Pract Res Clin Gastroenterol 19(3):401–412
Zar N, Holmberg L, Wilander E, Rastad J (1996) Survival in small intestinal adenocarcinoma. Eur J Cancer 12(9):2114–2119
Potter DD, Murray JA, Donohue JH, et al. (2004) The role of defective mismatch repair in small bowel adenocarcinoma in celiac disease. Cancer Res 64(19):7073–7077. doi:10.1158/0008-5472.can-04-1096
Castillo NE, Vanga RR, Theethira TG, et al. (2015) Prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US population. Am J Gastroenterol 110(8):1216–1222. doi:10.1038/ajg.2015.192
Sainsbury A, Sanders DS, Ford AC (2011) Meta-analysis: coeliac disease and hypertransaminasaemia. Aliment Pharmacol Ther 34(1):33–40. doi:10.1111/j.1365-2036.2011.04685.x
Vajro P, Paolella G, Maggiore G, Giordano G (2013) Pediatric celiac disease, cryptogenic hypertransaminasemia, and autoimmune hepatitis. J Pediatr Gastroenterol Nutr 56(6):663–670. doi:10.1097/MPG.0b013e31828dc5c5
Pastore L, Carroccio A, Compilato D, et al. (2008) Oral manifestations of celiac disease. J Clin Gastroenterol 42(3):224–232. doi:10.1097/MCG.0b013e318074dd98
Ch’ng CL, Jones MK, Kingham JG (2007) Celiac disease and autoimmune thyroid disease. Clin Med Res 5(3):184–192. doi:10.3121/cmr.2007.738
Betterle C, Lazzarotto F, Spadaccino AC, et al. (2006) Celiac disease in North Italian patients with autoimmune Addison’s disease. Eur J Endocrinol 154(2):275–279. doi:10.1530/eje.1.02089
Iltanen S, Collin P, Korpela M, et al. (1999) Celiac disease and markers of celiac disease latency in patients with primary Sjogren’s syndrome. Am J Gastroenterol 94(4):1042–1046. doi:10.1111/j.1572-0241.1999.01011.x
Szodoray P, Barta Z, Lakos G, Szakall S, Zeher M (2004) Coeliac disease in Sjogren’s syndrome—a study of 111 Hungarian patients. Rheumatol Int 24(5):278–282. doi:10.1007/s00296-003-0360-x
Ludvigsson JF, Rubio-Tapia A, Chowdhary V, Murray JA, Simard JF (2012) Increased risk of systemic lupus erythematosus in 29,000 patients with biopsy-verified celiac disease. J Rheumatol 39(10):1964–1970. doi:10.3899/jrheum.120493
Hwang E, McBride R, Neugut AI, Green PH (2008) Sarcoidosis in patients with celiac disease. Dig Dis Sci 53(4):977–981. doi:10.1007/s10620-007-9974-2
Dahan S, Shor DB, Comaneshter D, et al. (2016) All disease begins in the gut: celiac disease co-existence with SLE. Autoimmun Rev 15(8):848–853. doi:10.1016/j.autrev.2016.06.003
Rutherford RM, Brutsche MH, Kearns M, et al. (2004) Prevalence of coeliac disease in patients with sarcoidosis. Eur J Gastroenterol Hepatol 16(9):911–915
Lerner A, Matthias T (2015) Rheumatoid arthritis-celiac disease relationship: joints get that gut feeling. Autoimmun Rev 14(11):1038–1047. doi:10.1016/j.autrev.2015.07.007
Sorensen HT, Thulstrup AM, Blomqvist P, et al. (1999) Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. Gut 44(5):736–738
Muratori P, Fabbri A, Lalanne C, Lenzi M, Muratori L (2015) Autoimmune liver disease and concomitant extrahepatic autoimmune disease. Eur J Gastroenterol Hepatol 27(10):1175–1179. doi:10.1097/meg.0000000000000424
van Gerven NM, Bakker SF, de Boer YS, et al. (2014) Seroprevalence of celiac disease in patients with autoimmune hepatitis. Eur J Gastroenterol Hepatol 26(10):1104–1107. doi:10.1097/meg.0000000000000172
Stewart M, Andrews CN, Urbanski S, Beck PL, Storr M (2011) The association of coeliac disease and microscopic colitis: a large population-based study. Aliment Pharmacol Ther 33(12):1340–1349. doi:10.1111/j.1365-2036.2011.04666.x
Kochhar R, Masoodi I, Dutta U, et al. (2009) Celiac disease and Budd Chiari syndrome: report of a case with review of literature. Eur J Gastroenterol Hepatol 21(9):1092–1094. doi:10.1097/MEG.0b013e328328f47f
Ludvigsson JF, West J, Card T, Appelros P (2012) Risk of stroke in 28,000 patients with celiac disease: a nationwide cohort study in Sweden. J Stroke Cerebrovasc Dis 21(8):860–867. doi:10.1016/j.jstrokecerebrovasdis.2011.05.008
Ciacci C, Tortora R, Scudiero O, et al. (2009) Early pregnancy loss in celiac women: the role of genetic markers of thrombophilia. Dig Liver Dis 41(10):717–720. doi:10.1016/j.dld.2009.02.050
Malamut G, Chandesris O, Verkarre V, et al. (2013) Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study. Dig Liver Dis 45(5):377–384. doi:10.1016/j.dld.2012.12.001
Emilsson L, Lebwohl B, Sundstrom J, Ludvigsson JF (2015) Cardiovascular disease in patients with coeliac disease: a systematic review and meta-analysis. Dig Liver Dis 47(10):847–852. doi:10.1016/j.dld.2015.06.004
Emilsson L, Smith JG, West J, Melander O, Ludvigsson JF (2011) Increased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort study. Eur Heart J 32(19):2430–2437. doi:10.1093/eurheartj/ehr167
Compliance with ethical standards
Funding
No funding was received for this study.
Conflict of interest
The authors declare that they have no conflict of interest.
Disclosure
Joseph A. Murray (JAM): grant support from the National Institutes of Health (money paid to institution) and Alba Therapeutics (money paid to institution); Oberkotter Foundation (Oberkotter #1) (money paid to institution) and Broad Medical Research Program at CCFA (CCFA 342367) (money paid to institution); advisory boards Celimmune, LLC (money paid to JAM); AMAG Pharmaceuticals (money paid to JAM), Entera Health, Inc (money paid to JAM), Sonomaceuticals, LLC (money paid to JAM), BioLineRx (money paid to JAM), GlaxoSmithKline (GSK) (money paid to JAM), Genentech (money paid to JAM), Glenmark Pharmaceuticals Ltd (money paid to JAM); consultant to Boehringer Ingelheim (money paid to JAM); holds equity options in Torax (money paid to JAM and institution). Other authors declare that they have no disclosures.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Statement of informed consent was not applicable since the manuscript does not contain any patient data.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Al-Bawardy, B., Codipilly, D.C., Rubio-Tapia, A. et al. Celiac disease: a clinical review. Abdom Radiol 42, 351–360 (2017). https://doi.org/10.1007/s00261-016-1034-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-016-1034-y